МИНИСТЕРСТВО ЗДРАВООХРАНЕНИЯ УКРАИНЫ

is a severe disease of unknown cause, in which an increased eosinophil count (>1.5 ≈ 109/L for >6 weeks) leads to end-organ damage (endomyocardial fibrosis/restrictive cardiomyopathy, skin lesions, thrombo embolic disease, lung disease, neuropathy, and hepatospleno megaly). Oral steroids ± mepoli zumab (an anti-interleukin-5 monoclonal antibody). If FIP1L1-PDFRA genotype, dia g nose ... ................
................